Opportunities in the Next Generation Cancer Diagnostics Market include leveraging advancements in genomic and proteomic ...

Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...

Introduction While pathogen genomics using next-generation sequencing (NGS) has been recommended by the WHO as an essential ...

Programmatic control, AI integration, and automated workflows for high-frequency design.

Life sciences company Azenta (NASDAQ:AZTA) reported Q4 CY2025 results topping the market’s revenue expectations, but sales ...

Qiagen is a consumable molecular diagnostics and life-science tools platform and offers QuantiFERON, QIAstat-Dx, QIAcuity ...

Azenta, Inc. (NASDAQ:AZTA) Q1 2026 Earnings Call Transcript February 4, 2026 Azenta, Inc. misses on earnings expectations.

Engineered DNA can store massive amounts of data while also encrypting it, opening the door to ultra-secure, long-term ...

In March 2021,a doctor in a Nairobi hospital faced a wall of silence. Her patients werefalling ill with unprecedented speed, but the samples sat waiting, destined fora sequencing lab thousands of ...

With three new partnerships, 10x Genomics signals a move beyond research tools toward clinical diagnostics using its single-cell and spatial biology platforms.

Diploid Genomics, Inc. (DGI), an AI-driven advanced genomics analytics company, launches in partnership with Healthier Capital, a leading health-tech venture capital firm, under the leadership of ...

Interpretation is the discipline through which molecular datasets reveal their significance. As the life sciences enter a new era defined by data richness and technological capacity, interpretive ...